HHS continues to shovel money at Moderna for more mRNA Vaccines
It doesn't matter if their stock dips, Moderna is on the government dole
Press Releases one day after another.
Maybe they are splitting up the press releases to conceal how much actual money is going into the Cull Factory.
Rolling up on a billion here within two daze, going to various concerns with Moderna getting a big chunk.
January 16, 2025
$211-million
Today, the U.S. Department of Health and Human Services (HHS) announced it intends to provide $211 million to the Rapid Response Partnership Vehicle (RRPV) Consortium to enhance mRNA platform capabilities so that the U.S. is better prepared to respond to emerging infectious diseases like avian flu. This funding, from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR), will support development and long-term manufacturing capability of an RNA-based vaccine platform technology to combat evolving 21st century biothreats.
“We are continuing to take lessons learned during the COVID-19 pandemic to develop new vaccines and other tools to help augment our country’s pandemic response capabilities,” said HHS Secretary Xavier Becerra. “This latest intended investment illustrates the Biden-Harris Administration’s robust response to emerging disease threats such as avian influenza.”
“The funding will allow us to bring the benefits of mRNA vaccine technology to bear against a wider array of emerging threats,” said Assistant Secretary for Preparedness and Response Dawn O’Connell. “mRNA technology can be faster to develop and easier to update than other vaccines making it a helpful tool to have against viruses that move fast and mutate quickly.”
The RRPV is a 10-year, multi-purpose acquisition vehicle and consortium partnership designed to support advanced research and development of medical countermeasures, such as vaccines, therapeutics, and diagnostics. The consortium leverages ASPR's authority to create flexible, strategic partnerships between government and industry that foster innovation and promote collaboration.
The RRPV is currently soliciting proposal responses from mRNA vaccine developers. This program is the latest component of ASPR’s BARDA Influenza and Emerging Infectious Diseases Division’s medical countermeasure portfolio.
January 17, 2025
$590-million
The U.S. Department of Health and Human Services (HHS) will provide approximately $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines and enhance mRNA platform capabilities so that the U.S. is better prepared to respond to other emerging infectious diseases.
The award was made through the Rapid Response Partnership Vehicle (RRPV) Consortium with funding from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR).
This funding allows Moderna to accelerate development of an H5N1 mRNA influenza vaccine that is well matched to strains currently circulating in cows and birds and expands the clinical data supporting the use of mRNA vaccines that may be needed if other influenza strains emerge with pandemic potential.
“Avian flu variants have proven to be particularly unpredictable and dangerous to humans in the past. That is why this response has been a top priority for the Biden-Harris Administration and HHS,” said HHS Secretary Xavier Becerra. “Accelerating the development of new vaccines will allow us to stay ahead and ensure that Americans have the tools they need to stay safe.”
Moderna’s influenza vaccine candidate uses conventional mRNA technology that was leveraged successfully during the COVID-19 response, resulting in one of the first two FDA-authorized - and ultimately FDA-licensed - COVID-19 vaccines.
editor’s note: My sense is that the Big Swinging Dick of the USG budget, the DOD and the HHS Bioweapons Arm BARDA, still would very much like for you hammers in the warehouse to frame the manufacture of the kill shots as “public health” run through HHS with nebbish Dr. Jay Bhattacharyas and Anthony Faucis running point in various sub-agencies.
Roles and purpose of BARDA from Spookipedia
BARDA plays a unique and unusual role within the structure of the US Federal Government, assisting in getting drugs, deemed essential during public health emergencies including attacks compromising US national security, to market. Such assistance ranges from direct funding, procuring and stockpiling medical countermeasures (MCM’s), to helping obtain US FDA approvals, including Emergency Use Authorization (EUA) if needed. By the rare nature of such public health emergencies, the required therapies or countermeasures, while critical during the emergency, may not constitute a financially viable or profitable investment, for sufficiently large pharmaceutical companies.
Such gaps in the US government medical countermeasures infrastructure have been described as "bridging the valley of death".[8][6] In this respect, BARDA provides services similar to those offered by venture capitalists or business accelerators in private industry, although BARDA takes no financial stake in the final product once approved by the FDA.[9]
The Whole of Government.
“The award made today is part of the ASPR’s commitment to strengthening pandemic preparedness through investments in innovative technology such as mRNA vaccines,” said Assistant Secretary for Preparedness and Response Dawn O’Connell. “mRNA technology will complement existing vaccine technology, allowing us to move faster and better target emerging viruses to protect Americans’ against future pandemics.”
Here is Elegant Technology guy hand-waving away from what he knows is going to continue.
Public health “emergencies” and more kill shots.
In 2023, BARDA began working with Moderna to help develop mRNA vaccine to prepare for potential public health emergencies (PHEs) caused by influenza viruses, such as avian influenza A(H5N1).
In addition, Moderna will design and test an H7N9 mRNA pandemic influenza vaccine in a phase 3 clinical study. If successful, this vaccine potentially could become the first licensed for H7N9.
Moderna also will design up to four additional novel pandemic influenza vaccines and test preliminary safety and immunogenicity (generating an immune system response) in phase 1 clinical studies. This work will create the necessary background data to enable accelerated development of an mRNA vaccine targeted to various influenza virus subtypes of pandemic potential. This approach takes advantage of the versatility of Moderna’s mRNA platform, leveraging an existing manufacturing platform capability to support product development across multiple health threats.
The RRPV is a 10-year, multi-purpose acquisition vehicle and consortium partnership designed to support advanced research and development of medical countermeasures, such as vaccines, therapeutics, and diagnostics. The consortium leverages BARDA's authority to create flexible, strategic partnerships between government and industry that foster innovation and promote collaboration. BARDA also is providing funding to the RRPV for development of additional mRNA platform capacities.
This award is the latest component of the BARDA Influenza and Emerging Infectious Diseases Division’s medical countermeasure portfolio.
bUt We CaN sUe PfIzEr
pFiZeR bAd
wE dId It
“The funding will allow us to bring the benefits of mRNA vaccine technology to bear against a wider array of emerging threats"
👍 Sounds great, HHS. Cannot wait for the next "emerging threat" and the next round of "mRNA vaccine technology.
Peter McCullough told us the next rollout may be brighter! 🥳
-------
I guess we were all supposed to forget about Jabs Bad by now and focus on "Rescue the Republic".
I guess all those Jordon Walker/Sue Pfizer Ops and various Pacification and Control theatrical performances, all those hearings to empty rooms...were to put all the marks to sleep and gear up for mRNA Cancer Vaccines and mRNA "emerging pandemic" threats.
With Tier One, it was pedal to the metal. Straight on through. Gene editing. mRNA. Augment people. Test on people.
When in the F did 'Emerging Infectious Diseases' become a thing ?
And yes I heard about the Klimate change pangolin critter coming outta melting ice caps but no sign of #3's replacement. Much to the dismay of Froot Loops.